The acute phase reaction syndrome: The acute phase reactants: (A Review)

Acta Microbiologica et Immunologica Hungarica

Volumn 45, Issue 3-4, 1998, Pages 409-418

  Jakab, L ^a   Kalabay, L ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ANIMAL; HUMAN; IMMUNOLOGY; NERVOUS SYSTEM; PHYSIOLOGY; REVIEW; SYNDROME;

ACUTE-PHASE REACTION; ANIMALS; CYTOKINES; HUMANS; INTERLEUKIN-6; NERVOUS SYSTEM; SYNDROME;

EID: 0032251232     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Baumann, H., Gauldie, J.: The acute phase response. Immunol Today 15, 74 (1994).
2. Papnicolau, D.A., Wilder, R.L., Manolagas, S., Chrousos, G.P.: The pathologic roles of interleukin-6 in human disease. Ann Int Med 128, 127 (1998).
3. Tilg, H., Dinarello, C.A., Mier, J.W.: IL-6 and APP-s: antiinflammatory and immunosuppressive mediators. Immunol Today 18, 428 (1997).
4. Tilg, H., Trehu, E., Atkins, M.B., Dinarello, C.A., Mier, J.W.: Interleukin-6 (IL-6) as an anti-inflammatory cytokine. Blood 83, 113 (1994).
5. Taga, T., Kishimoto, T.: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15, 797 (1997).
6. Jakab, L.: The acute phase reaction of the organism. (In Hungarian). Orv Hetil 134, 567 (1993).
7. Jakab, L.: Pancreatitis acuta: inflammatory response syndrome of the organism. (In Hungarian). Orv Hetil 197, 2141 (1996).
8. Volanakis, J.E.: Transcriptional regulation of complement genes. Annu Rev Immunol 13, 277 (1995).
9. Gabay, C., Genin, B., Mentha, G., Lynedjian, P.B., Rox-Lombard, P., Guerne, P.-A.: IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Clin Exp Immunol 13, 277 (1995).
10. Banks, R.E., Forbes, M.A., Storr, M., Higginson, J., Thompson, D., Raynes, J., Illingnorth, J.M., Perren ,T.J., Selby, P.J., Whicher, J.T.: The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 102, 217 (1995).
11. Deehan, D.J., Heys, S.D., Simpson, W., Herriot, R., Broom, J., Eremin, O.: Correlation of serum cytokine and acute phase reactant levels with alterations in weight, and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol 95, 366 (1994).
12. Van Snick, J.: Interleukin-6: An overreview. Annu Rev Immunol 8, 253 (1990).
13. Wilder, R.L.: Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immmunol 13, 307 (1995).
14. Chrousos, G.P.: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl J Med 332, 1351 (1995).
15. Lipton, J.M., Catania, A.: Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 18, 140 (1997).
16. Smith, W.: Leukocyte-endothelial cell interactions. Semin Hematol 30 Suppl. 4, 45 (1993).
17. Adams, D.H., Shaw, S.: Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 343, 831 (1994).
18. Carlos, T.M., Harlan, J.M.: Leukocyte-endothelial adhesion molecules. Blood 84, 2068 (1994).
19. Bevilaqua, M.P., Nelson, R.M., Mannor, J.G., Cecconi, O.: Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 45, 361 (1994).
20. Price, T.H., Ochs, H.D., Gershoni-Baruch, R., Harlan, J.M., Entzioni, A.: In vivo neutrophil and lymphocyte function studies in patients with leukocyte adhesion deficiency type 2. Blood 84, 1635 (1994).
21. Ley, K., Zakrzewicz, A., Hanski, C., Stoolman, L.M., Kansas, G.S.: Sialylated O-glycans and L-selectin sequentially mediate myeloid cell rolling in vivo. Blood 85, 3727 (1995).
22. Luscinskas, F.W., Gimborne, M.A.: Endothelial dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 47, 413 (1996).
23. Ebnet, K., Kaldjian, E.P., Anderson, A.O., Shaw, S.: Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol 14, 155 (1996).
24. Jakab, L.: New aspects in the pathogenesis of polyarthritis chronica progressiva (RA). (In Hungarian). Orv Hetil 134, 2133 (1993).
25. Jakab, L.: The physiological and pathophysiological role of adhesion molecules. (In Hungarian). Lege Artis Medicinae 4, 810 (1994).
26. Jakab, L., Kalabay, L.: The physiological and clinical role of selectins. (In Hungarian). Lege Artis Medicinae 6, 284 (1996).
27. Wilckens, T., DeRijk, R.: Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18, 418 (1997).
28. Anderlik, P., Szeri, I., Bános, Zs., Barna, Zs., Kalabay, L., Jakab, L.: Effect of mannozym treatment on plasma fibronectin concentration in germfree and conventional mice. Acta Microbiol Hung 37, 295 (1990).
29. Anderlik, P., Szeri, I., Bános, Zs., Barna, Zs., Cseh, K., Kalabay, L.: Influence of thymus and the microflora on the plasma fibronectin concentration in mice. Acta Microbiol Hung 40, 159 (1993).
30. DeGraaf, T.W., Van der Stelt, M., Anbergen, M.G., van Dijk, W.: Inflammation-induced expression of sialyl LewisX-containing glycan structures and on α1-acid glycoprotein (orosomucoid) in human sera. Exp Med 177, 657 (1993).
31. Eigler, A., Sinha, B., Hartmann, G., Endres, S.: Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 18, 487 (1997).
32. Smith, J.W., McDonald, T.L.: Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone. Clin Exp Immunol 90, 293 (1992).
33. Vasse, M., Paysant, J., Soria, J., Nirshahi, S.S., Vanier, J.P., Sorja, C.: Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Brit J Haematol 93, 955 (1996).
34. Reiser, H., Stadecker, M.J.: Costimulatory B7 molecules in the pathogenesis of infections and autoimmune diseases. New Engl J Med 335, 1369 (1996).
35. Ransohoff, R.M.: Cellular responses to interferons and other cytokines.: The JAK-STAT paradigm. New Engl J Med 338, 616 (1998).
36. Barnes, P.J., Karin, M.: Nuclear factor-κB-A pivotal transcription factor in chronic inflammatory diseases. New Eng J Med 336, 1066 (1997).
37. Kremer, M.H., Wilting, J., Janssen, H.M.: Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 40, 1 (1988).
38. Tedder, T.F., Tuscano, J., Sato, S., Kehr, J.H.: CD22, a lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 15, 481 (1997).
39. Jakab, L., Jakab, L., Kalabay, L., Pozsonyi, T., Cseh, K.: The effect of the α2-HS-glycoprotein on the mitogen-induced lymphoblastic transformation and IL-2 production. Acta Physiol Hung 77, 25 (1991).
40. Kalabay, L., Chavin, K., Lebreton, J.-P., Robinson, K.A., Buse, M.G., Arnaud, P.: Human recombinant alpha2-HS glycoprotein is produced in insect cells as a full length inhibitor of insulin receptor tyrosine kinase. Horm Metab Res 30, 1 (1998).
41. Kalabay, L., Jakab, L., Arnaud, P.: α2-HS glycoprotein: How much do we know about it at present? (In Hungarian). Lege Artis Medicinae 7, 492 (1998).
42. Weis, W.I., Drickamer, K.: Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem 65, 441 (1996).
43. Sinkovics, J., Horák, A.: Interleukin-6 (IL-6). (In Hungarian). Orv Hetil 138, 2838 (1997).